Is Urine Sterile? The Urobiome and UTIs

Is urine sterile?

Urine is not sterile. A healthy bladder contains a community of bacteria, viruses, and fungi. The myth of sterile urine came from a threshold, proposed in 1957, to determine when a standard urine culture is positive for a UTI. This criterion is based on the count of colony-forming units (CFU) per milliliter of urine and sets a threshold at a count of 100,000 or more. That cutoff was established more than 75 years ago and remains in use today even though these cutoff points were not sufficiently validated¹.

Because standard urine culture protocols use a very small amount of urine, grow it under a limited range of conditions, and report a result only when growth crosses the 100,000 CFU/mL threshold, organisms present a lower count or those that need different growing conditions are underreported or missed completely.

Urine was excluded from the Human Microbiome Project (HMP), a National Institutes of Health initiative launched in 2007 to characterize the microbial communities living on and in humans, because of the myth of sterility. That exclusion left the urinary microbiome relatively unstudied for years, however, the ideas and techniques promoted by the HMP eventually busted the myth²³.

Today, many UTIs are still evaluated with standard urine culture and the outdated threshold, which runs into the same limitations that created the myth in the first place. Even among patients with characteristic UTI symptoms and an abnormal urine examination, bacterial growth is often not detected¹. If you have ever received “negative” or “no growth” culture results while still having symptoms, an advanced diagnostic test may identify something standard urine culture did not.

What is the urobiome?

The urobiome — also called the urinary microbiome or bladder microbiome — is the community of microorganisms that lives in the urinary tract. It includes bacteria, fungi, and viruses, though the bacterial component has been studied far more than the other two. Its composition differs greatly across individuals, with age and sex among the strongest influences, and understanding those differences is an active research area¹³.

The origin of the urobiome is not fully known. The gut and vaginal microbiomes, along with the external environment, have been proposed as the primary colonization sources¹.

Bacteria

Bacteria are the best-studied part of the urobiome. In women, several Lactobacillus species are found in the healthy urobiome, and some appear able to impede Escherichia coli growth in the urinary tract⁴. One small study of postmenopausal women with recurrent UTIs found a relative increase in Lactobacillus crispatus was associated with treatment success, though the study included only 17 participants⁵. In male urobiomes, Corynebacterium species are frequently the most prevalent³.

Bacteria reported across studies of healthy urobiomes

Across the studies, it was found that relative abundance varies substantially between individuals¹³⁴. Note that while Lactobacilli have been identified in the male urethral microbiota, their presence in the male bladder microbiota is less certain⁴.

Fungi (the mycobiome)

The fungal portion of the urobiome is sometimes called the urinary mycobiome. Considerably less is known about the role of fungi in the urinary tract than about bacteria, and their interactions within the urobiome are not well characterized¹³. Candida species are among the fungi reported in the urobiome, and they can act as commensals or, in some patients, as pathogens. Fungi are a known blind spot for routine testing: standard bacterial urine culture is not designed to grow them³.

Viruses (the virome)

The urobiome includes eukaryotic viruses as well as bacteriophages, which infect bacteria and may be a key factor in shaping the community². Viruses reported in the bladder include human papillomavirus, polyomavirus, and cytomegalovirus, and these have been implicated in chronic inflammation¹. The virome's role in urinary health, and its interaction with the rest of the urobiome in both health and disease, still requires further investigation¹².

How did we learn that urine is not sterile?

Two different approaches overturned the sterile-bladder idea: better culture and an advanced molecular technology called next-generation sequencing.

Better culture: Enhanced Quantitative Urine Culture

Researchers modified the standard urine culture protocol by plating a larger volume of urine, incubating it under varied conditions, and letting it grow longer. This approach is called enhanced (or expanded) quantitative urine culture, or EQUC.

The results were striking. In a 2014 study of 65 catheterized urine specimens, EQUC grew bacteria from 80% of samples and the large majority of those samples had been reported as no growth by the clinical laboratory using the standard protocol. Across those samples, EQUC identified 35 different genera and 85 different species⁶. EQUC can detect growth at levels as low as 10 CFU/mL. By comparison, standard urine culture was designed to grow specific expected uropathogens³.

This is a useful thing to understand about the myth: the bacteria were always there. The standard protocol simply was not built to find them.

Next-generation sequencing

Sequencing takes a different route. Instead of growing organisms, it reads their genetic material directly from the sample. Two approaches come up most often:

• 16S rRNA sequencing reads one specific bacterial gene. It is a good survey tool for describing which bacterial groups are present in a community and it was central to early urobiome research. However, it struggles to distinguish closely related organisms, measures abundance only imprecisely, and does not detect fungi or viruses³.
• Shotgun metagenomic sequencing reads all the genetic material in a sample rather than a single gene. This allows for identification across bacteria, fungi, and viruses, and it can also detect genes associated with antimicrobial resistance. When this approach is used in a clinical setting to aid in diagnosis, it is called clinical metagenomic sequencing.

Because sequencing does not depend on an organism's ability to grow in a laboratory, it can identify organisms that culture misses — including organisms present in low numbers, slow-growing or anaerobic organisms, and organisms suppressed by recent antibiotic use.

If a healthy bladder has bacteria, what counts as an infection?

This is the most important question in the whole conversation, and it has a clear answer: finding bacteria in urine is not the same as having a UTI. Because the urinary tract is colonized by commensal or “healthy” bacteria, it is not uncommon to find bacteria in urine samples, even when not actively experiencing symptoms. As such, test results should be interpreted alongside your symptoms and your clinical history, not on their own.

Asymptomatic bacteriuria

Asymptomatic bacteriuria (ASB) means one or more bacterial species are growing in the urine at high counts — conventionally 100,000 CFU/mL or more, regardless of whether pyuria is present — in someone with no signs or symptoms attributable to a UTI⁷⁸. ASB is a common finding in some healthy women and in many people with urinary tract abnormalities that affect bladder emptying⁷.

Professional guidelines generally recommend against screening for or treating ASB in most populations, with specific exceptions such as pregnancy and certain urologic procedures. One reason is that treating ASB is a recognized source of unnecessary antibiotic use, which contributes to antimicrobial resistance⁷.

Contamination

Contamination happens when organisms from the skin, the area around the urethra, or the vagina end up in the sample during collection rather than coming from the bladder. Bacteria commonly colonize the vaginal introitus and the periurethral area, and, in women, it is difficult to collect a voided sample without some vaginal contamination³⁸. Following sample collection instructions precisely is important to reduce the risk of contamination.

Urinary tract infection

A urinary tract infection involves symptoms — such as burning with urination, urgency, frequency, pelvic or lower abdominal pain, or in some cases fever and flank pain — together with evidence that a pathogen is present and, usually, signs of inflammation¹. The organism, the inflammation, and the symptoms are read together to make a UTI diagnosis.

The practical takeaway: bacteria on a report, by itself, is not a sufficient reason for antibiotics⁷⁸.

Diagnostic uncertainty for UTIs

Urine sample collection method matters

How a sample is collected changes how confidently it can be interpreted. Because there is still no single standard method for collecting and analyzing urine, comparing different studies is difficult³.

If you are providing a urine sample, follow your provider's or the laboratory's collection instructions closely. Careful collection is one of the few parts of this process a patient can directly control, and it meaningfully affects how usable the result is.

What about a positive urinalysis and a negative culture?

Urinalysis is usually the first test performed, and it looks for signs of inflammation rather than identifying an organism. Two findings come up often:

• Pyuria means white blood cells are elevated in the urine. It is a sign of inflammation in the urinary tract.
• Nitrites and leukocyte esterase on a dipstick are indirect signals that can suggest bacterial infection.

When there is pyuria but the urine culture comes back negative, this is sometimes called sterile pyuria. It is a recognized clinical scenario, not a contradiction. There is inflammation, but the culture did not name a cause. This combination is not rare: in one report, 24% of patients who presented with typical lower UTI symptoms and pyuria had no bacterial growth on conventional urine culture¹. Possible explanations include an organism that standard culture cannot readily grow, recent antibiotic use, an organism present at counts below the reporting threshold, or a non-infectious cause of inflammation.

Sterile pyuria is one of the situations in which a broader identification method, like a clinical metagenomic-based diagnostic test, may add information that standard culture does not.

Does a UTI always show up in a urine culture?

No. Standard urine culture, while widely used and often readily available, has known limitations. Importantly, a negative result does not rule out infection in a symptomatic patient¹. A culture-negative UTI — sometimes described as a “no growth” result despite ongoing symptoms — can occur for several reasons:

• The organism is present below the reporting threshold. Standard protocols report growth only above a set CFU count¹.
• The organism does not grow well under standard conditions. Anaerobes, slow-growing organisms, and fastidious organisms are commonly missed³⁶.
• Recent antibiotic use suppressed growth. Some uropathogens can enter a viable but nonculturable state after antibiotic treatment, meaning they are still present but will not multiply on standard culture media¹.
• The organism is sheltered in a biofilm or inside bladder cells. In that state, relatively few organisms may be free-floating in the urine sample¹.
• The causative organism is a fungus or virus. Standard bacterial culture is not designed to detect these³.

If you are experiencing repeated symptoms alongside repeated negative cultures, that pattern is worth raising with your provider directly.

How does the urobiome change during disease?

Dysbiosis means an imbalance in a microbial community. Potentially pathogenic bacteria normally coexist with native organisms in a dynamic balance; when that balance is disrupted, pathogenic strains may become predominant and cause symptoms¹.

A healthy urobiome appears to help control pathogenic microorganisms, modulate the immune response, and support a healthy mucosal barrier. Changes in its composition have been associated with a range of bladder conditions, including urgency urinary incontinence, overactive bladder syndrome, interstitial cystitis/bladder pain syndrome, benign prostatic hyperplasia, bladder cancer, and UTIs¹³.

Decreased Lactobacillus has been linked to UTIs, urgency, urinary incontinence, and overactive bladder, and reduced urobiome diversity has been correlated with symptom severity in urgency and urinary incontinence³. Conversely, urine from patients with interstitial cystitis and bladder pain syndrome has shown decreased overall diversity alongside increased levels of Lactobacillus³⁸.

The composition of a healthy urobiome is not one-size-fits-all, and more research is needed. Whether these changes are primarily causative or correlative has yet to be determined³. What is clear is that the urobiome is a dynamic system, and changes within it can cause and/or co-occur with disease.

Why do UTIs keep coming back?

Reinfection from external sources is possible, but recurrent UTIs are often caused by the same pathogen emerging from a reservoir inside the patient or rebounding after treatment failure.

Biofilms and intracellular bacterial communities in UTIs

A biofilm is a structured community of bacteria that attaches to a surface — such as the bladder lining or a catheter — and surrounds itself with a protective matrix. Bacteria inside a biofilm behave differently from free-floating bacteria: they are harder for antibiotics to reach, harder for the immune system to clear, and less likely to appear in a urine sample in large numbers. Biofilm formation is thought to underlie many chronic lower urinary tract symptoms, and can itself contribute to increased antibiotic resistance³.

Intracellular bacterial communities (IBCs) are clusters of bacteria living inside the cells lining the bladder or uroepithelial cells. E. coli can invade superficial urothelial cells early in infection and multiply inside them, forming biofilm-like multicellular structures that escape the immune response and resist antibiotics with low intracellular penetration. Uropathogenic E. coli can also form quiescent intracellular reservoirs, which are more persistent than IBCs and sit in deeper layers of the uroepithelium¹.

Estimates suggest at least half of people with UTIs have intracellular bacteria¹. Bacteria in these structures can be protected from both antibiotics and the immune system and may not be detected as free-swimming bacteria in urine using standard diagnostic methods¹.

During treatment of an initial infection, pathogenic bacterial populations can drop below diagnostic thresholds, stop causing symptoms temporarily, and/or persist in biofilms or IBCs, only to later reseed the bladder. Symptoms may be temporarily relieved because the bacterial load falls, while the potential for recurrence remains¹. A healthy urobiome may provide protection against these recurring infections¹⁸.

Recurrent, chronic, and embedded UTI

You may encounter several different terms and they are not interchangeable:

• Recurrent UTI generally refers to repeated, distinct episodes of infection separated by symptom-free intervals. Commonly defined as two episodes in six months or three in twelve months⁹.
• Chronic UTI is used, particularly within patient communities and by some clinicians, to describe persistent symptoms that never fully resolve, rather than discrete episodes. Where UTI is chronic and persistent, it may be driven by organisms other than the usual acute uropathogens, which is one reason standard urine culture can miss it³.
• Embedded UTI is a related term describing bacteria persisting within the bladder wall.

“Chronic UTI” and “embedded UTI” are not universally adopted clinical designations and definitions vary between practitioners.

Antimicrobial resistance and the urobiome

Antimicrobial resistance is a growing concern, not only for our ability to treat UTIs, but also for its impact on the urobiome.

Antibiotics and other antimicrobial drugs reshape the urobiome. Antibiotics do not act only on pathogenic bacteria – they can affect healthy microbes as well. Antibiotic therapy for UTI has been shown to deplete resident organisms in the urinary tract, including lactobacilli, which can leave the urobiome more vulnerable to overgrowth by potentially pathogenic organisms¹³. Antibiotic use has also been associated with an increased risk of recurrent UTI, and recent antibiotic exposure is a risk factor for carrying resistant uropathogens⁸.

Unnecessary antibiotic use drives resistance. UTIs are among the most common reasons antibiotics are prescribed, which makes UTI care a significant contributor to overall antibiotic exposure¹⁸. Treating asymptomatic bacteriuria is a well-documented example of avoidable antibiotic use⁷. Just because bacteria is found in your urine does not mean it is causing harm or requires treatment.

Empiric treatment can miss the target. Because culture results take days, patients are typically treated empirically in the meantime, and ambiguity in current diagnostic guidelines contributes to unnecessary use of broad-spectrum antibiotics¹. If the actual organism is resistant to the empiric choice, the result can be treatment failure, another course of antibiotics, and further disruption of the urobiome.

Updated models of recurrent UTI care place more emphasis on antimicrobial stewardship — confirming the diagnosis, delaying antibiotic initiation where it is safe to do so, and using antibiotics judiciously — alongside supporting the protective microbiome rather than relying on repeated eradication¹⁰.

Identifying the organism and understanding its resistance profile, is what makes it possible to move away from repeated empiric cycles.

How do you support a healthy urobiome?

Given the relationship between an imbalanced urobiome and disease, researchers have looked at non-antibiotic approaches that might help reduce recurrent UTIs. This matters for two reasons: overuse of antibiotics is a major driver of antimicrobial resistance and antibiotics can deplete protective Lactobacillus species, contributing to dysbiosis¹⁴⁸.

These approaches are being explored as complements to standard medical care, not replacements for it. The quality of evidence differs a great deal from one to the next, and for several of them the honest summary is that we do not yet know. Nothing here should be started, stopped, or substituted for prescribed treatment without talking to your provider.

One further non-antibiotic option is not listed below because it acts on the urine rather than on the urobiome: methenamine salts, a urinary antiseptic, appear alongside vaginal estrogen in current prevention guidance and are worth asking your provider about¹⁰.

A note on cranberry

Cranberry's most-discussed active compounds are proanthocyanidins, or PACs, which are thought to interfere with the ability of E. coli to adhere to the bladder lining. Cranberry also contains other antibacterial compounds, including D-mannose⁸. One review of 50 studies found moderate-certainty evidence that cranberry products reduced the risk of symptomatic, culture-verified UTIs overall, with benefit concentrated in specific groups: women with recurrent UTIs, children, and people made susceptible to UTI by a medical intervention. The same review did not find benefit in older institutionalized adults, pregnant women, or adults with incomplete bladder emptying and found no clear relationship between PAC dose and effect¹⁵.

A note on probiotics

Lactobacilli are commensal bacteria that can suppress uropathogens, which is the rationale for taking probiotics⁸. The clinical evidence, however, remains weak. A review found that probiotics alone were not significantly better than antibiotics or placebo at reducing UTI risk, though those results were limited by small participant numbers and unclear or high risk of bias across most included studies⁸. Trials have also varied widely in the strains used and in how and how often they were administered, which makes them difficult to compare⁴.

Because the benefits of a healthy microbial community depend on complex interactions rather than any single organism, supplementing one species may not be enough to restore balance on its own⁸.

How is the urobiome connected to the vaginal and gut microbiomes?

The vaginal microbiome

The vaginal microbiome is closely linked to the urinary tract, both anatomically and in the species found. Loss of protective vaginal Lactobacillus species increases the risk of UTI. Women with recurrent UTIs often show increased E. coli colonization alongside depletion of hydrogen peroxide-producing lactobacilli, and those lacking these lactobacilli have been found to have a roughly five-fold increased risk of vaginal E. coli colonization. Changes in the vaginal microbiome can follow from low vaginal estrogen, antibiotic use, certain contraceptives, and other causes⁸. Vaginal and urinary conditions can also produce overlapping symptoms, which is one reason they are sometimes mistaken for one another.

Menopause significantly alters the female vaginal and urinary microbiomes. Lactobacillus species are the most prevalent organisms in premenopausal women, while postmenopausal women show a different profile and a general decrease in overall microbial diversity. This loss of Lactobacilli is thought to contribute to increased postmenopausal susceptibility to recurrent UTIs³.

The clinical evidence supporting the use of vaginal estrogen to reduce the frequency of UTIs is the strongest of any non-antibiotic option discussed. Five randomized controlled trials have found that low-dose vaginal estrogen — as creams, tablets, rings, or gels — reduced culture-confirmed recurrent UTI episodes, and it is recommended for this purpose in current guidelines¹². One practical caveat: most vaginal estrogen products are licensed for genitourinary syndrome of menopause rather than specifically for UTI prevention, so this use sits outside the approved labeling even though trials and guidelines support it¹². Discuss with your provider whether vaginal estrogen may be right for you.

The gut microbiome

The gut microbiome is a recognized reservoir for uropathogens. In the majority of cases, microbes from the gut are the source of the bacterial strains that cause cystitis and pyelonephritis, which is one reason gut and urinary health are studied together⁸.

Some researchers have gone further and proposed a bladder-gut-brain axis, in which stress, intestinal conditions, and even social and emotional factors may influence the development of urogenital disorders. Patients with bladder conditions accompanied by depression or anxiety have shown significant differences in urobiome structure compared with those without. This remains an emerging area of research¹.

What is next for urobiome research?

The myth of sterile urine has been thoroughly disproved, first by enhanced culture and then by the widespread use of next-generation sequencing in research and clinical practice. Much more work remains, including:

• Defining what a healthy urobiome looks like across different patient populations, ages, and sexes — differences between healthy individuals are large enough that “normal” is still difficult to define¹³
• Understanding interactions with the gut, vaginal, and skin microbiomes
• Characterizing the fungal and viral portions of the urobiome, which lag well behind bacterial research
• Standardizing how urine is collected and analyzed, so results can be compared across studies³
• Establishing which non-antibiotic strategies meaningfully reduce UTI risk and in whom
• Clarifying whether urobiome changes in conditions beyond infection are causative or correlative³

The direction is clear, even if the details are not settled: the bladder is not sterile and testing with outdated thresholds will continue to produce incomplete answers.

The BIOTIA-ID Urine Test

If you have recurrent or complicated UTIs, ask your provider about the BIOTIA-ID Urine Test.

Many UTIs are evaluated using standard urine culture. As described above, culture has known limitations: organisms present in low counts, organisms sheltered in biofilms or IBCs, and organisms that do not grow readily under standard conditions can all go unreported.

The BIOTIA-ID Urine Test uses next-generation sequencing — the same category of technology used to study the urobiome — and is designed to detect and identify UTI pathogens, including organisms that may be present in low counts. It also provides information about antibiotic resistance to help your provider select the treatment that may work best. It is available for at-home collection across all 50 U.S. states. Moreover, by testing with Biotia patients are able to receive virtual care from a Clinova Solutions provider that specializes in UTI testing and treatment, particularly for challenging cases.